TickerFacts.

A business in context

GSK research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 6-K · Current report

    Report date 2026-09-01 · 0001654954-26-008044

  2. 6-K · Current report

    Report date 2026-09-01 · 0001654954-26-007998

  3. 6-K · Current report

    Report date 2026-08-26 · 0001654954-26-007877

  4. 6-K · Current report

    Report date 2026-08-24 · 0001654954-26-007810

  5. 6-K · Current report

    Report date 2026-08-24 · 0001654954-26-007800

  6. 6-K · Current report

    Report date 2026-08-24 · 0001654954-26-007798

  7. 6-K · Current report

    Report date 2026-08-18 · 0001654954-26-007718

  8. 6-K · Current report

    Report date 2026-08-13 · 0001654954-26-007560

  9. 6-K · Current report

    Report date 2026-08-11 · 0001654954-26-007453

  10. 6-K · Current report

    Report date 2026-08-03 · 0001654954-26-007176

  11. 6-K · Current report

    Report date 2026-07-30 · 0001654954-26-007005

  12. 6-K · Current report

    Report date 2026-07-28 · 0001654954-26-006954

  13. 6-K · Current report

    Report date 2026-07-28 · 0001654954-26-006951

  14. 6-K · Current report

    Report date 2026-07-28 · 0001654954-26-006949

  15. 6-K · Current report

    Report date 2026-07-24 · 0001654954-26-006862

  16. 6-K · Current report

    Report date 2026-07-24 · 0001654954-26-006854

  17. 6-K · Current report

    Report date 2026-07-22 · 0001654954-26-006789

  18. 6-K · Current report

    Report date 2026-07-20 · 0001654954-26-006735

  19. 6-K · Current report

    Report date 2026-07-17 · 0001654954-26-006706

  20. 6-K · Current report

    Report date 2026-07-17 · 0001654954-26-006705

  21. 6-K · Current report

    Report date 2026-07-16 · 0001654954-26-006691

  22. 6-K · Current report

    Report date 2026-07-15 · 0001654954-26-006663

  23. 6-K · Current report

    Report date 2026-07-14 · 0001654954-26-006640

  24. 6-K · Current report

    Report date 2026-07-13 · 0001654954-26-006623

  25. 6-K · Current report

    Report date 2026-07-13 · 0001654954-26-006614

  26. 6-K · Current report

    Report date 2026-07-10 · 0001654954-26-006601

  27. 6-K · Current report

    Report date 2026-07-09 · 0001654954-26-006560

  28. 6-K · Current report

    Report date 2026-07-09 · 0001654954-26-006557

  29. 6-K · Current report

    Report date 2026-07-01 · 0001654954-26-006424

  30. 6-K · Current report

    Report date 2026-06-29 · 0001654954-26-006273

  31. 6-K · Current report

    Report date 2026-06-29 · 0001654954-26-006269

  32. 6-K · Current report

    Report date 2026-06-26 · 0001654954-26-006220

  33. 4 · Ownership change

    Report date 2025-12-11 · 0001999371-25-020336

  34. 4 · Ownership change

    Report date 2024-09-27 · 0001999371-24-012789

  35. 4 · Ownership change

    Report date 2023-12-07 · 0001999371-24-001192

  36. 4 · Ownership change

    Report date 2022-09-16 · 0001387131-22-009897

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001131399GSK plc
GSKStiefel LaboratoriesGlaxoSmithKline (Germany)GlaxoSmithKline (Italy)GlaxoSmithKline (Belgium)GlaxoSmithKline (Croatia)GlaxoSmithKline (Ireland)GlaxoSmithKline (United States)GlaxoSmithKline (Canada)GlaxoSmithKline (Australia)GlaxoSmithKline (Poland)GlaxoSmithKline (Sri Lanka)GlaxoSmithKline Turkey

Showing 13 of 13 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
5493000HZTVUYLO1D793
GLEIF legal name
GSK PLC
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2026-04-15T14:12:41Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • GSK · subsidiary · wikidata
  • GlaxoSmithKline plc · alias · wikidata
  • Glaxo Smith Kline · alias · wikidata
  • GlaxoSmithKline · subsidiary · wikidata
  • Glaxo · alias · wikidata
  • Stiefel Laboratories · subsidiary · wikidata
  • GlaxoSmithKline (Germany) · subsidiary · wikidata
  • GlaxoSmithKline (Italy) · subsidiary · wikidata
  • GlaxoSmithKline (Belgium) · subsidiary · wikidata
  • Glaxosmithkline Pharmaceuticals · subsidiary · wikidata
  • GlaxoSmithKline (Croatia) · subsidiary · wikidata
  • GlaxoSmithKline (Ireland) · subsidiary · wikidata
  • GlaxoSmithKline (United States) · subsidiary · wikidata
  • GlaxoSmithKline (Canada) · subsidiary · wikidata
  • GlaxoSmithKline (Australia) · subsidiary · wikidata
  • GlaxoSmithKline (Poland) · subsidiary · wikidata
  • GlaxoSmithKline (Sri Lanka) · subsidiary · wikidata
  • GlaxoSmithKline Turkey · subsidiary · wikidata
  • GSK Japan · subsidiary · wikidata
  • GlaxoSmithKline K.K. · subsidiary · wikidata
  • GLAXOSMITHKLINE PLC · former SEC name · 2001-05-14 to 2022-05-16
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

No USD annual revenue periods with complete CPI coverage are available. Non-USD statements are not converted with U.S. CPI.

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗